Clinical trial
Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are…
NCT00045292 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00045292 |
|---|---|
| Title | Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation |
| Official title | A Phase III Multicenter Study of Cytomegalovirus Prophylaxis With Valacyclovir for the Prevention of Serious Fungal and Bacterial Infections Among Cytomegalovirus Seronegative Recipients of Cytomegalovirus Seropositive Sx Stem Cell Transplants |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | acyclovir, acyclovir sodium, valacyclovir |
| Start date | Apr 1, 2002 |
| Completion | Oct 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 21, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: